Elevated plasma vitamin B12 levels and cancer prognosis: A population-based cohort study

Cancer Epidemiology

Volumn 40, Issue , 2016, Pages 158-165

  Arendt, Johan Frederik Håkonsen ^a   Farkas, Dóra Körmendiné ^a   Pedersen, Lars ^a   Nexo, Ebba ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cancer; Cohort studies; Epidemiology; Mortality; Registries; Vitamin B 12

Indexed keywords

CYANOCOBALAMIN; TUMOR MARKER;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; SEX; SURVIVAL RATE; VERY ELDERLY; VITAMIN BLOOD LEVEL; BLOOD; DENMARK; INFANT; MIDDLE AGED; NEOPLASMS; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; RISK ASSESSMENT; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DENMARK; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; VITAMIN B 12; YOUNG ADULT;

EID: 84960089929     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2015.12.007     Document Type: Article

References (40)

1. Stabler S.P. Clinical practice. Vitamin B12 deficiency. N. Engl. J. Med. 2013, 368:149-160.
2. Arendt J.F., Nexo E. Unexpected high plasma cobalamin: proposal for a diagnostic strategy. Clin. Chem. Lab. Med. 2013, 51:489-496.
3. Arendt J.F., Pedersen L., Nexo E., Sorensen H.T. Elevated plasma vitamin B12 levels as a marker for cancer: a population-based cohort study. J. Natl. Cancer Inst. 2013, 105:1799-1805.
4. Arendt J.F., Nexo E. Cobalamin related parameters and disease patterns in patients with increased serum cobalamin levels. PLoS One 2012, 7:e45979.
5. Brah S., Chiche L., Mancini J., Meunier B., Arlet J.B. Characteristics of patients admitted to internal medicine departments with high serum cobalamin levels: results from a prospective cohort study. Eur. J. Intern. Med. 2014, 25:e57-e58.
6. Carmel R., Vasireddy H., Aurangzeb I., George K. High serum cobalamin levels in the clinical setting -clinical associations and holo-transcobalamin changes. Clin. Lab. Haematol. 2001, 23:365-371.
7. Chiche L., Jean R., Romain F., Roux F., Thomas G., Canavese S., et al. Clinical implications of high cobalamin blood levels for internal medicine. Rev. Med. Interne 2008, 29:187-194.
8. Ryg J., Nybo M., Hallas J. Cancer incidence in persons with elevated cobalamin levels. Eur. J. Clin. Invest. 2013, 43:557-561.
9. Carmel R., Eisenberg L. Serum vitamin B12 and transcobalamin abnormalities in patients with cancer. Cancer 1977, 40:1348-1353.
10. Geissbühler P., Mermillod B., Rapin C.H. Elevated serum vitamin B12 levels associated with CRP as a predictive factor of mortality in palliative care cancer patients: a prospective study over five years. J. Pain Symptom Manag. 2000, 20:93-103.
11. Hemmersbach-Miller M., Conde-Martel A., Betancor-Leon P. Vitamin B12 as a predictor of mortality in elderly patients. J. Am. Geriatr. Soc. 2005, 53:2035-2036.
12. Kelly L., White S., Stone P.C. The B12/CRP index as a simple prognostic indicator in patients with advanced cancer: a confirmatory study. Ann. Oncol. 2007, 18:1395-1399.
13. Lin C.Y., Kuo C.S., Lu C.L., Wu M.Y., Huang R.F. Elevated serum vitamin B12 levels in association with tumor markers as the prognostic factors predictive for poor survival in patients with hepatocellular carcinoma. Nutr. Cancer 2010, 62:190-197.
14. Tavares F. Is the B12/CRP index more accurate than you at predicting life expectancy in advanced cancer patients?. J. Pain Symptom Manag. 2010, 40:e12-e13.
15. Baztan J.J., Gavidia J.J., Gomez-Pavon J., Esteve A., Ruiperez I. High vitamin B12 levels and in-hospital mortality. J. Am. Geriatr. Soc. 2010, 58:2237-2238.
16. Salles N., Herrmann F., Sakbani K., Rapin C.H., Sieber C. High vitamin B12 level: a strong predictor of mortality in elderly inpatients. J. Am. Geriatr. Soc. 2005, 53:917-918.
17. Sviri S., Khalaila R., Daher S., Bayya A., Linton D.M., Stav I., et al. Increased vitamin B12 levels are associated with mortality in critically ill medical patients. Clin. Nutr. 2011, 31:53-59.
18. Tal S., Shavit Y., Stern F., Malnick S. Association between vitamin B12 levels and mortality in hospitalized older adults. J. Am. Geriatr. Soc. 2010, 58:523-526.
19. Grossfeld A., Dekel S., Lerman Y., Sherman S., Atzmony L., Salai M., et al. Symptomatic venous thromboembolism in elderly patients following major orthopedic surgery of the lower limb is associated with elevated vitamin B12 serum levels. Clin. Biochem. 2013, 46:54-58.
20. Dangour A.D., Breeze E., Clarke R., Shetty P.S., Uauy R., Fletcher A.E. Plasma homocysteine, but not folate or vitamin B-12, predicts mortality in older people in the United Kingdom. J. Nutr. 2008, 138:1121-1128.
21. Gonzalez S., Huerta J.M., Fernandez S., Patterson A.M., Lasheras C. Homocysteine increases the risk of mortality in elderly individuals. Br. J. Nutr. 2007, 97:1138-1143.
22. Callaghan F.M., Leishear K., Abhyankar S., Demner-Fushman D., McDonald C.J. High vitamin B12 levels are not associated with increased mortality risk for ICU patients after adjusting for liver function: a cohort study. ESPEN J. 2014, 9:e76-e83.
23. Grann A.F., Erichsen R., Nielsen A.G., Froslev T., Thomsen R.W. Existing data sources for clinical epidemiology: the clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin. Epidemiol. 2011, 3:133-138.
24. Ehrenstein V., Antonsen S., Pedersen L. Existing data sources for clinical epidemiology: Aarhus University Prescription Database. Clin. Epidemiol. 2010, 2:273-279.
25. Gjerstorff M.L. The Danish cancer registry. Scand. J. Public Health 2011, 39:42-45.
26. Lynge E., Sandegaard J.L., Rebolj M. The Danish national patient register. Scand. J. Public Health 2011, 39:30-33.
27. Schmidt M., Pedersen L., Sorensen H.T. The Danish Civil Registration System as a tool in epidemiology. Eur. J. Epidemiol. 2014, 29:541-549.
28. Laboratory reference intervals for Northern Denmark (updated 24th of January 2011). (accessed 3.06.15.). http://https://laboratorieliste.rn.dk/prog/d_udskriftsvenlig_udgave.aspx%3Fid=179.
29. Berlin H., Berlin R., Brante G. Oral treatment of pernicious anemia with high doses of vitamin B12 without intrinsic factor. Acta Med. Scand. 1968, 184:247-258.
30. Cochran W.G. Some methods for strengthening the common chi-squared tests. Biometrics 1954, 10:417-451.
31. Armitage P. Tests for linear trends in proportions and frequencies. Biometrics 1955, 11:375-386.
32. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987, 40:373-383.
33. Sterne J.A., White I.R., Carlin J.B., Spratt M., Royston P., Kenward M.G., et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009, 338:b2393.
34. Eisemann N., Waldmann A., Katalinic A. Imputation of missing values of tumour stage in population-based cancer registration. BMC Med. Res. Methodol. 2011, 11:129.
35. Marshall A., Altman D.G., Royston P., Holder R.L. Comparison of techniques for handling missing covariate data within prognostic modelling studies: a simulation study. BMC Med. Res. Methodol. 2010, 10:7.
36. Ulvik A., Ebbing M., Hustad S., Midttun O., Nygard O., Vollset S.E., et al. Long- and short-term effects of tobacco smoking in circulating concentrations of B vitamins. Clin. Chem. 2010, 56:755-763.
37. Ganji V., Kafai M.R. Serum total homocysteine concentration determinants in non-Hispanic White, non-Hispanic Black, and Mexican-American populations of the United States. Ethn. Dis. 2004, 14:476-482.
38. Bor M.V., Lydeking-Olsen E., Moller J., Nexo E. A daily intake of approximately 6 microg vitamin B-12 appears to saturate all the vitamin B-12-related variables in Danish postmenopausal women. Am. J. Clin. Nutr. 2006, 83:52-58.
39. Lam J.R., Schneider J.L., Zhao W., Corley D.A. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 2013, 310:2435-2442.
40. Niafar M., Hai F., Porhomayon J., Nader N.D. The role of metformin on vitamin B12 deficiency: a meta-analysis review. Intern. Emerg. Med. 2015, 10:93-102.